ABL

Abbott Laboratories · XETR:ABL

97.24 EUR2.00 +2.10%

Abbott Laboratories (XETR:ABL) last traded at 97.24 EUR, up 2.10% on the day. Over the past year the stock is down 9.46%. Its 52-week range is 70.10 to 113.36. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open95.32

Day range94.78 – 97.24

52-week range70.10 – 113.36

Volume787

Average volume (10 days)656

Market cap (USD)183.77 B

P/E40.67

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)0.3618

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+5.65%1 week

+13.04%1 month

+4.58%3 months

+30.03%6 months

−9.43%Year to date

−9.46%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.